Cargando…
Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice
Prostate cancer (PCa) is the most frequent malignancy in older men with a high propensity for bone metastases. Characteristically, PCa causes osteosclerotic lesions as a result of disrupted bone remodeling. Extracellular vesicles (EVs) participate in PCa progression by conditioning the pre-metastati...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836054/ https://www.ncbi.nlm.nih.gov/pubmed/35163219 http://dx.doi.org/10.3390/ijms23031285 |
_version_ | 1784649582520565760 |
---|---|
author | Furesi, Giulia de Jesus Domingues, Antonio Miguel Alexopoulou, Dimitra Dahl, Andreas Hackl, Matthias Schmidt, Johannes R. Kalkhof, Stefan Kurth, Thomas Taipaleenmäki, Hanna Conrad, Stefanie Hofbauer, Christine Rauner, Martina Hofbauer, Lorenz C. |
author_facet | Furesi, Giulia de Jesus Domingues, Antonio Miguel Alexopoulou, Dimitra Dahl, Andreas Hackl, Matthias Schmidt, Johannes R. Kalkhof, Stefan Kurth, Thomas Taipaleenmäki, Hanna Conrad, Stefanie Hofbauer, Christine Rauner, Martina Hofbauer, Lorenz C. |
author_sort | Furesi, Giulia |
collection | PubMed |
description | Prostate cancer (PCa) is the most frequent malignancy in older men with a high propensity for bone metastases. Characteristically, PCa causes osteosclerotic lesions as a result of disrupted bone remodeling. Extracellular vesicles (EVs) participate in PCa progression by conditioning the pre-metastatic niche. However, how EVs mediate the cross-talk between PCa cells and osteoprogenitors in the bone microenvironment remains poorly understood. We found that EVs derived from murine PCa cell line RM1-BM increased metabolic activity, vitality, and cell proliferation of osteoblast precursors by >60%, while significantly impairing mineral deposition (−37%). The latter was further confirmed in two complementary in vivo models of ossification. Accordingly, gene and protein set enrichments of osteoprogenitors exposed to EVs displayed significant downregulation of osteogenic markers and upregulation of proinflammatory factors. Additionally, transcriptomic profiling of PCa-EVs revealed the abundance of three microRNAs, miR-26a-5p, miR-27a-3p, and miR-30e-5p involved in the suppression of BMP-2-induced osteogenesis in vivo, suggesting the critical role of these EV-derived miRNAs in PCa-mediated suppression of osteoblast activity. Taken together, our results indicate the importance of EV cargo in cancer-bone cross-talk in vitro and in vivo and suggest that exosomal miRNAs may contribute to the onset of osteosclerotic bone lesions in PCa. |
format | Online Article Text |
id | pubmed-8836054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88360542022-02-12 Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice Furesi, Giulia de Jesus Domingues, Antonio Miguel Alexopoulou, Dimitra Dahl, Andreas Hackl, Matthias Schmidt, Johannes R. Kalkhof, Stefan Kurth, Thomas Taipaleenmäki, Hanna Conrad, Stefanie Hofbauer, Christine Rauner, Martina Hofbauer, Lorenz C. Int J Mol Sci Article Prostate cancer (PCa) is the most frequent malignancy in older men with a high propensity for bone metastases. Characteristically, PCa causes osteosclerotic lesions as a result of disrupted bone remodeling. Extracellular vesicles (EVs) participate in PCa progression by conditioning the pre-metastatic niche. However, how EVs mediate the cross-talk between PCa cells and osteoprogenitors in the bone microenvironment remains poorly understood. We found that EVs derived from murine PCa cell line RM1-BM increased metabolic activity, vitality, and cell proliferation of osteoblast precursors by >60%, while significantly impairing mineral deposition (−37%). The latter was further confirmed in two complementary in vivo models of ossification. Accordingly, gene and protein set enrichments of osteoprogenitors exposed to EVs displayed significant downregulation of osteogenic markers and upregulation of proinflammatory factors. Additionally, transcriptomic profiling of PCa-EVs revealed the abundance of three microRNAs, miR-26a-5p, miR-27a-3p, and miR-30e-5p involved in the suppression of BMP-2-induced osteogenesis in vivo, suggesting the critical role of these EV-derived miRNAs in PCa-mediated suppression of osteoblast activity. Taken together, our results indicate the importance of EV cargo in cancer-bone cross-talk in vitro and in vivo and suggest that exosomal miRNAs may contribute to the onset of osteosclerotic bone lesions in PCa. MDPI 2022-01-24 /pmc/articles/PMC8836054/ /pubmed/35163219 http://dx.doi.org/10.3390/ijms23031285 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Furesi, Giulia de Jesus Domingues, Antonio Miguel Alexopoulou, Dimitra Dahl, Andreas Hackl, Matthias Schmidt, Johannes R. Kalkhof, Stefan Kurth, Thomas Taipaleenmäki, Hanna Conrad, Stefanie Hofbauer, Christine Rauner, Martina Hofbauer, Lorenz C. Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice |
title | Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice |
title_full | Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice |
title_fullStr | Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice |
title_full_unstemmed | Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice |
title_short | Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice |
title_sort | exosomal mirnas from prostate cancer impair osteoblast function in mice |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836054/ https://www.ncbi.nlm.nih.gov/pubmed/35163219 http://dx.doi.org/10.3390/ijms23031285 |
work_keys_str_mv | AT furesigiulia exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT dejesusdominguesantoniomiguel exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT alexopouloudimitra exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT dahlandreas exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT hacklmatthias exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT schmidtjohannesr exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT kalkhofstefan exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT kurththomas exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT taipaleenmakihanna exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT conradstefanie exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT hofbauerchristine exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT raunermartina exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice AT hofbauerlorenzc exosomalmirnasfromprostatecancerimpairosteoblastfunctioninmice |